Biomerica Inc.: The Newport Beach company said...
- Share via
Biomerica Inc.: The Newport Beach company said Monday it has signed a marketing agreement that could double sales of its EZ Detect test stool samples for blood. Under the agreement, General Injectables & Vaccines Inc. of Radford, Va., will have exclusive rights to market Biomerica’s product in the United States. Biomerica, which develops and markets medical tests, expects sales of at least $4 million during the first three years of the contract.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
